RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+2.83%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.31B
AUM Growth
+$3.31B
(-16%)
Cap. Flow
-$387M
Cap. Flow
% of AUM
-11.67%
Top 10 Holdings %
Top 10 Hldgs %
35.65%
Holding
121
New
8
Increased
41
Reduced
28
Closed
10
Top Buys
| 1 |
Insmed
INSM
|
$54.2M |
| 2 |
Johnson & Johnson
JNJ
|
$24.8M |
| 3 |
Structure Therapeutics
GPCR
|
$23.1M |
| 4 |
UnitedHealth
UNH
|
$22.9M |
| 5 |
Eli Lilly
LLY
|
$16.5M |
Top Sells
| 1 |
Immunocore
IMCR
|
$66M |
| 2 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$44M |
| 3 |
Penumbra
PEN
|
$43.2M |
| 4 |
Boston Scientific
BSX
|
$32M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$31.1M |
Sector Composition
| 1 | Healthcare | 97.63% |
| 2 | Consumer Staples | 1.87% |
| 3 | Industrials | 0.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Oscar Health
OSCR
$4.57B
| $19.8M | 0.6% |
1,251,500
-858,500
| -41% | -$13.6M |
|
52
Nuvalent
NUVL
$5.74B
| $19.4M | 0.58% |
255,989
+130,687
| +104% | +$9.91M |
|
53
Krystal Biotech
KRYS
$4.35B
| $19.4M | 0.58% |
105,569
+1,600
| +2% | +$294K |
|
54
Inspire Medical Systems
INSP
$2.53B
| $17.4M | 0.52% |
130,000
-500
| -0.4% | -$66.9K |
|
|
INZY
55
DELISTED
Inozyme Pharma
INZY
| $16.5M | 0.5% |
3,698,374
+17,200
| +0.5% | +$76.7K |
|
56
Dyne Therapeutics
DYN
$1.92B
| $16.3M | 0.49% |
461,028
+9,204
| +2% | +$325K |
|
57
Dynavax Technologies
DVAX
$1.19B
| $14.5M | 0.44% |
1,292,637
-382,837
| -23% | -$4.3M |
|
58
Pharvaris
PHVS
$1.41B
| $14.2M | 0.43% |
756,931
+4,007
| +0.5% | +$75.3K |
|
|
59
Immunocore
IMCR
$1.78B
| $14.2M | 0.43% |
419,030
-1,948,786
| -82% | -$66M |
|
60
Vera Therapeutics
VERA
$1.47B
| $13.8M | 0.42% |
381,192
+40,024
| +12% | +$1.45M |
|
61
Crinetics Pharmaceuticals
CRNX
$3.26B
| $13M | 0.39% |
289,400
| – | – |
|
62
Prothena Corp
PRTA
$452M
| $12.9M | 0.39% |
625,048
| – | – |
|
|
OLK
63
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $12.7M | 0.38% |
500,000
-1,176,500
| -70% | -$30M |
|
64
Charles River Laboratories
CRL
$7.99B
| $12.4M | 0.37% |
60,250
+11,750
| +24% | +$2.43M |
|
65
BioMarin Pharmaceuticals
BMRN
$11.3B
| $12.4M | 0.37% |
151,000
+2,168
| +1% | +$178K |
|
66
Amicus Therapeutics
FOLD
$2.42B
| $12.1M | 0.36% |
1,218,580
+65,924
| +6% | +$654K |
|
|
NVRO
67
DELISTED
NEVRO CORP.
NVRO
| $11.6M | 0.35% |
1,381,500
+316,500
| +30% | +$2.66M |
|
68
Cullinan Oncology
CGEM
$456M
| $11.5M | 0.35% |
+658,338
| New | +$11.5M |
|
69
Enliven Therapeutics
ELVN
$1.24B
| $10M | 0.3% |
428,571
| – | – |
|
70
Jasper Therapeutics
JSPR
$44.2M
| $9.18M | 0.28% |
404,335
| – | – |
|
71
Novavax
NVAX
$1.2B
| $8.55M | 0.26% |
675,000
+137,375
| +26% | +$1.74M |
|
|
ACCD
72
DELISTED
Accolade, Inc. Common Stock
ACCD
| $8.2M | 0.25% |
2,290,000
-1,250,000
| -35% | -$4.48M |
|
|
EDAP
73
EDAP TMS
EDAP
$103M
| $8.02M | 0.24% |
1,475,000
| – | – |
|
|
SWTX
74
DELISTED
SpringWorks Therapeutics
SWTX
| $7.53M | 0.23% |
+199,855
| New | +$7.53M |
|
75
Neumora Therapeutics
NMRA
$283M
| $7.47M | 0.22% |
760,007
+113,889
| +18% | +$1.12M |
|